Contributor (866) 529-2400 Studies in Japan and in Norway may contribute to the body of analysis of Mirena side effects. Bayers Mirena intrauterine device has been the subject of lawsuits in which plaintiffs have reported one or more severe adverse reactions, including: Approved by the U.S. Food and Drug Administration in 2000, the Mirena IUD is inserted by a health care professional for pregnancy prevention. The FDA in 2009 broadened the indications of this levonorgestrel intrauterine system to treat heavy menstrual bleeding in women who use intrauterine contraception as their method of pregnancy prevention. The U.S. National Institutes of Health as of this writing had not posted the results of a Bayer-sponsored observational study in Japan that tracked from 2007 to 2012 550 Mirena IUD patients. One of the studys goals was to observe the incidence of adverse drug reactions, especially pelvic inflammatory disease, in women who are inserted Mirena. Additionally, a segment of the scientific and regulatory communities await the results of a study sponsored by the University Hospital of North Norway in which 200 patients with low risk endometrial hyperplasia ages 30 to 70 will receive one of three treatments. The Mirena IUD is one of them. The … Continue reading →

Dallas, Texas (PRWEB) March 21, 2013 The birth control safety advocates at DrugRisk.com are alerting women whove used the vaginal ring contraceptive NuvaRing of updated legal news added to the site - the federal court where more than 1,000 NuvaRing injury claims await litigation has delayed the start of trials until October. DrugRisk was created with the goal of improving patient safety through clear information. By providing the latest drug alerts, research, legal news and recalls, patients can see if others are experiencing similar side effects and decide if they need legal advice, explains DrugRisk representative Ryan Mayer. Health experts have linked contraceptives like NuvaRing to higher risks of blood clots than traditional birth control pills. Last year, the New England Journal of Medicine published a study finding vaginal ring contraceptives could relate to a 2.5 to 3-fold increased risk of blood clots*. DrugRisk has also compiled the latest figures from the FDA, which show more than 5,300 adverse reports have been filed among women using NuvaRing devices.** The most common side effects were 1,177 occurrences of pulmonary embolism and 1,155 reports of thrombosis or deep vein thrombosis. Over 30% of cases resulted in hospitalization while 3% ended in death**. … Continue reading →

The Firm is currently investigating lawsuits on behalf of individuals injured as a result of drug side effects, including those caused by Fosamax. New York, New York (PRWEB) March 20, 2013 The importance of this case cannot be understated. Weve already seen numerous lawsuits involving generic drugs dismissed because of the Mensing decision. A decision in favor of generic drug makers will close off the last remaining legal avenue open to victims of of defective generic medications, says Bernstein Liebhard LLP. The Firm offers free legal evaluations to individuals who have allegedly suffered injuries due to Fosamax and other medications. Generic Drug Lawsuits Under U.S. Food & Drug Administration (FDA) regulations, generic drugs are required to carry the very same label warnings as name-brand versions. In 2011, the U.S. Supreme Court ruled in Pliva vs. Mensing that manufacturers of generic medications could not be held liable for failing to warn patients about their risks since they have no control over the content of the drugs labels. (Pliva v. Mensing, 131 S. Ct. 2567 (2011)) According to a report published by the New York Times in the wake of the Mensing decision, lawsuits involving generic versions of have since faced dismissal … Continue reading →

http://www.DrugRisks.com is the most helpful resource on the web for prescription medication alerts, side effects and legal news. Visit us today! Philadelphia, PA (PRWEB) March 21, 2013 DrugRisks was created to provide those taking popular prescription drugs with the latest safety alerts, recalls, studies and legal news. Visitors can determine if other patients are experiencing similar side effects and decide if they need legal advice for current litigation. Health experts with the FDA** and European Medicines Agency*** have warned patients that long-term use of Actos may be linked to increased risks of bladder cancer. The drug has also been banned in France and Germany****. The maker of Actos, Takeda Pharmaceuticals, now faces Actos lawsuits from as many as 3,000 patients over bladder cancer*****. Over 1,200 of these have been consolidated in a special multi-district federal court in Louisiana, while others are pending in California. DrugRisks has added information showing the first Actos lawsuit trial in California* began this month for a man dying of bladder cancer*****. Also, a former pharmacologist for Takeda testified that company emails suggested they were more concerned with continued sales of the drug rather than the safety of patients*****. Although trials have begun, lawyers are still … Continue reading →

A group of researchers from the Stanford, University School of Medicine and Microsoft Research have found a way to use the internet and web searches to discover previously unreported side effects of commonly used drugs. According to a Time magazine report, the study was able to mine anonymous data from 82 million drug-symptom and condition searches. These searches came from six million internet volunteers who agreed to let the researchers install a Microsoft plug-in that would monitor their search history for a year. The most dramatic finding of this study is the previously unreported drug interaction between paroxetine, an anti-depressant, and pravastatin, a drug that lowers cholesterol. Theyve discovered that 10% of searches involving both paroxetine and pravastatin (implying that the searcher is using both drugs) also searched for hyperglycemia or high blood sugar; a condition that produces symptoms like chronic fatigue, blurry vision and weight loss. But searches that involve paroxetine alone or pravastatin alone have fewer hyperglycemia-related searches (5% for paroxetine, 4% for pravastatin). This implies that searchers who take both drugs maybe experiencing drug interactions that made them more susceptible to hyperglycemia. The team then sent their results to the US FDA, which confirmed that joint use … Continue reading →

Gilman Law LLP represents victims of drug side effects and medical device injuries, including those allegedly associated with Stryker Hip Implants, Biomet Hip Implants, the Da Vinci Surgical System, the Mirena IUD, GranuFlo and NaturaLyte Dialysis Drugs, and the Byetta diabetes medication. Boston, MA (PRWEB) March 20, 2013 The defective drug and products liability law firm of Gilman Law LLP can provide a free legal consultation with no cost or obligation to individuals that have been injured by a defective drug or defective medical device. Contact our defective drug lawyers TOLL FREE at 888-252-0048 or submit a free legal consultation form online. The Supreme Courts Upcoming Decision May Limit Consumer Rights On March 18th, the Supreme Court heard oral arguments in another generic drug case, Bartlett v. Mutual Pharm. Co., Inc. According to Ken Gilman of Gilman Law, LLP, "Depending on the Courts decision in Bartlett, consumers could lose additional rights to recover for the victims of generic drug injuries." Unfortunately, most consumers are not aware of the Mensing or Bartlett decisions, or that they may not be able to recover for injuries against generic drug manufacturers according to Gilman Law. (Mutual Pharmaceutical Co. v. Bartlett, 12-142.) In response to … Continue reading →